Novolin



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 33.3%
Type 1 Diabetes Mellitus 28.6%
Type 2 Diabetes Mellitus 28.6%
Off Label Use 4.8%
Weight Increased 4.8%
Abnormal Weight Gain 10.0%
Blood Glucose Fluctuation 10.0%
Hypoglycaemia 10.0%
Insulin Autoimmune Syndrome 10.0%
Myocardial Infarction 10.0%
Renal Impairment 10.0%
Suicide Attempt 10.0%
Suspected Counterfeit Product 10.0%
Syncope 10.0%
Urinary Incontinence 10.0%
Secondary
Type 2 Diabetes Mellitus 44.0%
Diabetes Mellitus 20.0%
Type 1 Diabetes Mellitus 8.0%
Hypertension 6.0%
Product Used For Unknown Indication 6.0%
Blood Glucose 4.0%
Blood Glucose Increased 2.0%
Depression 2.0%
Immunodeficiency Common Variable 2.0%
Metastases To Bone 2.0%
Oesophageal Carcinoma 2.0%
Staphylococcal Infection 2.0%
Diabetes Mellitus Inadequate Control 8.3%
Injection Site Bruising 8.3%
Nausea 8.3%
Pancytopenia 8.3%
Blood Bilirubin Increased 4.2%
Diarrhoea 4.2%
Drug Hypersensitivity 4.2%
Drug Ineffective 4.2%
Hypertension 4.2%
Hypoglycaemia 4.2%
Injection Site Haemorrhage 4.2%
Injection Site Pain 4.2%
Rash Macular 4.2%
Renal Failure Acute 4.2%
Renal Tubular Necrosis 4.2%
Retinal Vein Thrombosis 4.2%
Retinopathy 4.2%
Suicide Attempt 4.2%
Syncope 4.2%
Type I Hypersensitivity 4.2%
Concomitant
Drug Use For Unknown Indication 42.8%
Product Used For Unknown Indication 19.2%
Diabetes Mellitus 8.1%
Hypertension 6.1%
Type 2 Diabetes Mellitus 4.1%
Pain 3.1%
Hiv Infection 2.4%
Depression 1.9%
Prophylaxis 1.4%
Hepatitis C 1.4%
Chronic Obstructive Pulmonary Disease 1.3%
Cardiac Disorder 1.1%
Arthritis 1.0%
Diabetes Mellitus Non-insulin-dependent 1.0%
Atrial Fibrillation 1.0%
Blood Cholesterol Increased 0.9%
Constipation 0.9%
Sciatica 0.9%
Osteoporosis 0.8%
Osteoarthritis 0.8%
Vomiting 19.7%
Weight Decreased 12.0%
Weight Increased 10.3%
Myocardial Infarction 5.7%
Sepsis 5.3%
Type 2 Diabetes Mellitus 5.0%
Death 4.7%
Pain 4.7%
Transient Ischaemic Attack 4.3%
Platelet Count Decreased 4.0%
Urinary Tract Infection 4.0%
Nausea 3.7%
Renal Failure Chronic 2.3%
Therapeutic Agent Toxicity 2.3%
Dyspnoea 2.0%
Febrile Neutropenia 2.0%
Tricuspid Valve Incompetence 2.0%
Type 1 Diabetes Mellitus 2.0%
Vision Blurred 2.0%
White Blood Cell Count Decreased 2.0%